A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of MK-3475 in Combination With INCB024360 in Subjects With Selected Cancers - Regional Cancer Care Associates LLC

Clinical Trials

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of MK-3475 in Combination With INCB024360 in Subjects With Selected Cancers

Type of Cancer
Solid Tumor
Locations
Bethesda
Sponsor
Incyte Corporation
Protocol Number
INCB 24360-202
Cancer Diagnosis
To Learn More Call
201-510-0910